Wegovy is specifically FDA-approved for chronic weight management in adults and adolescents aged 12 years and older with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity (e.g., hypertension, type 2 diabetes, dyslipidemia) [8] [9]
Fernandes, A.P
The most prominent growth trend involves the transition from reliance on injectables for GLP-1 treatment towards oral agents that may increase patient convenience as well as help address issues associated with injection fatigue
Otherwise, try to prioritize protein and fiber, such as whole grains, to help yourself feel full and reduce the chance of snacking from hunger between meals
We provide comprehensive, medically supervised weight management combined with access to post-weight loss body contouring
Whilst improved insulin sensitivity generally has favourable hormonal effects, rapid weight loss can temporarily disrupt hormone levels, including sex hormones and cortisol